Skip to main content

Advertisement

Table 1 Incidence of JAZF1/SUZ12 fusion transcript in uterine ESTs

From: JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas

First author (year) ESN +/total (%) LG-ESS +/total (%) UES +/total (%) Normal endometrium +/total (%) Total Nr. of analyzed ESTs Informative for JAZF1/SUZ12 (%)
Koontz (2001) [3] 3/3 (100) 5/5 (100) 3/7 (43) 0/10 (0) 15 15 (100)
Micci (2003) [18] - 1/4 (25) - - 4 4 (100)
Huang (2004) [6] 2/2 (100) 3/13 (23) - - 15 15 (100)
Hrzenjak (2005) [7] - 16/20 (80) 0/2 (0) 0/10 (0) 22 22 (100)
Micci (2006) [36] - 0/3 (0) - - 3 3 (100)
Oliva (2007) [10] 3/6 (50) 0/1 (0) - - 10 6 (60)
Nucci (2007) [8] 4/4 (100) 8/16 (50) - - 32 20 (63)
Kurihara (2008, 2010) [9, 12] 4/6 (67) 5/11 (45) 1/6 (17) - 37 23 (62)
Li (2007) [33] 4/4 (100) - - - 4 4 (100)
D'Angelo (2013) [37] 1/3 (33) 1/13 (8) 0/7 (0) - 23 22 (96)
Isphording (2013) [45] - 7/16 (44) 0/6 (0) - 22 22 (100)
Total (%) 21/28 (75) 46/102 (45) 4/28 (14) 0/20 (0) 187 156 (83)
  1. Abbreviations: ESN endometrial stromal nodule, LG-ESS low-grade endometrial stromal sarcoma, UES undifferentiated endometrial sarcoma, + positive for JAZF1/SUZ12 gene fusion; total, number of all analyzed samples